Decreased in‐hospital mortality associated with aspirin administration in hospitalized patients due to severe COVID‐19

Hypercoagulability and thrombosis caused by coronavirus disease 2019 (COVID‐19) are related to the higher mortality rate. Because of limited data on the antiplatelet effect, we aimed to evaluate the impact of aspirin add‐on therapy on the outcome of the patients hospitalized due to severe COVID‐19....

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Med Virol
Päätekijät: Haji Aghajani, Mohammad, Moradi, Omid, Amini, Hossein, Azhdari Tehrani, Hamed, Pourheidar, Elham, Rabiei, Mohammad M., Sistanizad, Mohammad
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2021
Aiheet:
Research Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8242852/
https://ncbi.nlm.nih.gov/pubmed/33913549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.27053
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia